TNFRSF12A: Difference between revisions

Jump to navigation Jump to search
m (1 revision imported)
 
(One intermediate revision by one other user not shown)
Line 3: Line 3:


==Clinical significance==
==Clinical significance==
[[NFAT1]] regulates the expression of TWEAKR (this protein) and its ligand [[TNFSF12|TWEAK]] with [[LCN2|lipocalin 2]] to increase breast cancer cell invasion.<ref name="pmid22767506">{{cite journal | vauthors = Gaudineau B, Fougère M, Guaddachi F, Lemoine F, de la Grange P, Jauliac S | title = Lipocalin 2, the TNF-like receptor TWEAKR and its ligand TWEAK act downstream of NFAT1 to regulate breast cancer cell invasion | journal = J. Cell Sci. | volume = 125 | issue = Pt 19 | pages = 4475–86 |date=October 2012 | pmid = 22767506 | doi = 10.1242/jcs.099879 }}</ref>
[[NFAT1]] regulates the expression of TWEAKR (this protein) and its ligand [[TNFSF12|TWEAK]] with [[LCN2|lipocalin 2]] to increase breast cancer cell invasion.<ref name="pmid22767506">{{cite journal | vauthors = Gaudineau B, Fougère M, Guaddachi F, Lemoine F, de la Grange P, Jauliac S | title = Lipocalin 2, the TNF-like receptor TWEAKR and its ligand TWEAK act downstream of NFAT1 to regulate breast cancer cell invasion | journal = J. Cell Sci. | volume = 125 | issue = Pt 19 | pages = 4475–86 |date=October 2012 | pmid = 22767506 | doi = 10.1242/jcs.099879 | url = http://www.hal.inserm.fr/docs/00/71/58/76/PDF/jcs.099879.full.pdf }}</ref>


==References==
==References==
Line 26: Line 26:
*{{cite journal  |vauthors=Tran NL, McDonough WS, Savitch BA, etal |title=Increased fibroblast growth factor-inducible 14 expression levels promote glioma cell invasion via Rac1 and nuclear factor-kappaB and correlate with poor patient outcome |journal=Cancer Res. |volume=66 |issue= 19 |pages= 9535–42 |year= 2007 |pmid= 17018610 |doi= 10.1158/0008-5472.CAN-06-0418 }}
*{{cite journal  |vauthors=Tran NL, McDonough WS, Savitch BA, etal |title=Increased fibroblast growth factor-inducible 14 expression levels promote glioma cell invasion via Rac1 and nuclear factor-kappaB and correlate with poor patient outcome |journal=Cancer Res. |volume=66 |issue= 19 |pages= 9535–42 |year= 2007 |pmid= 17018610 |doi= 10.1158/0008-5472.CAN-06-0418 }}
*{{cite journal  |vauthors=Girgenrath M, Weng S, Kostek CA, etal |title=TWEAK, via its receptor Fn14, is a novel regulator of mesenchymal progenitor cells and skeletal muscle regeneration |journal=EMBO J. |volume=25 |issue= 24 |pages= 5826–39 |year= 2007 |pmid= 17124496 |doi= 10.1038/sj.emboj.7601441  | pmc=1698888 }}
*{{cite journal  |vauthors=Girgenrath M, Weng S, Kostek CA, etal |title=TWEAK, via its receptor Fn14, is a novel regulator of mesenchymal progenitor cells and skeletal muscle regeneration |journal=EMBO J. |volume=25 |issue= 24 |pages= 5826–39 |year= 2007 |pmid= 17124496 |doi= 10.1038/sj.emboj.7601441  | pmc=1698888 }}
*{{cite journal  |vauthors=Dogra C, Hall SL, Wedhas N, etal |title=Fibroblast growth factor inducible 14 (Fn14) is required for the expression of myogenic regulatory factors and differentiation of myoblasts into myotubes. Evidence for TWEAK-independent functions of Fn14 during myogenesis |journal=J. Biol. Chem. |volume=282 |issue= 20 |pages= 15000–10 |year= 2007 |pmid= 17383968 |doi= 10.1074/jbc.M608668200 }}
*{{cite journal  |vauthors=Dogra C, Hall SL, Wedhas N, etal |title=Fibroblast growth factor inducible 14 (Fn14) is required for the expression of myogenic regulatory factors and differentiation of myoblasts into myotubes. Evidence for TWEAK-independent functions of Fn14 during myogenesis |journal=J. Biol. Chem. |volume=282 |issue= 20 |pages= 15000–10 |year= 2007 |pmid= 17383968 |doi= 10.1074/jbc.M608668200 |pmc=4149055 }}
{{refend}}
{{refend}}



Latest revision as of 09:18, 10 January 2019

VALUE_ERROR (nil)
Identifiers
Aliases
External IDsGeneCards: [1]
Orthologs
SpeciesHumanMouse
Entrez
Ensembl
UniProt
RefSeq (mRNA)

n/a

n/a

RefSeq (protein)

n/a

n/a

Location (UCSC)n/an/a
PubMed searchn/an/a
Wikidata
View/Edit Human

Tumor necrosis factor receptor superfamily member 12A also known as the TWEAK receptor (TWEAKR) is a protein that in humans is encoded by the TNFRSF12A gene.[1][2][3]

Clinical significance

NFAT1 regulates the expression of TWEAKR (this protein) and its ligand TWEAK with lipocalin 2 to increase breast cancer cell invasion.[4]

References

  1. Feng SL, Guo Y, Factor VM, Thorgeirsson SS, Bell DW, Testa JR, Peifley KA, Winkles JA (Jun 2000). "The Fn14 Immediate-Early Response Gene Is Induced During Liver Regeneration and Highly Expressed in Both Human and Murine Hepatocellular Carcinomas". Am J Pathol. 156 (4): 1253–61. doi:10.1016/S0002-9440(10)64996-6. PMC 1876890. PMID 10751351.
  2. Meighan-Mantha RL, Hsu DK, Guo Y, Brown SA, Feng SL, Peifley KA, Alberts GF, Copeland NG, Gilbert DJ, Jenkins NA, Richards CM, Winkles JA (Jan 2000). "The mitogen-inducible Fn14 gene encodes a type I transmembrane protein that modulates fibroblast adhesion and migration". J Biol Chem. 274 (46): 33166–76. doi:10.1074/jbc.274.46.33166. PMID 10551889.
  3. "Entrez Gene: TNFRSF12A tumor necrosis factor receptor superfamily, member 12A".
  4. Gaudineau B, Fougère M, Guaddachi F, Lemoine F, de la Grange P, Jauliac S (October 2012). "Lipocalin 2, the TNF-like receptor TWEAKR and its ligand TWEAK act downstream of NFAT1 to regulate breast cancer cell invasion" (PDF). J. Cell Sci. 125 (Pt 19): 4475–86. doi:10.1242/jcs.099879. PMID 22767506.

Further reading

This article incorporates text from the United States National Library of Medicine, which is in the public domain.